Michael D. Lesh
Algemeen Directeur bij Syntegra, Inc. /California/
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michel Darnaud | M | 74 | 14 jaar | |
Andrew Buckler | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 15 jaar |
Marie Meynadier | M | 62 | 10 jaar | |
Tom Coles | M | - | 10 jaar | |
Ofer Mendelevitch | M | - |
Syntegra, Inc. /California/
Syntegra, Inc. /California/ Packaged SoftwareTechnology Services Syntegra, Inc. applies machine learning to create validated replicas of medical data. The company was founded by Michael Lesh and Ofer Mendelevitch and is headquartered in Mill Valley, CA. | - |
Bhaskar Ramamurthy | M | - |
Cordance Medical, Inc.
Cordance Medical, Inc. Medical SpecialtiesHealth Technology Cordance Medical, Inc. is a company that is developing the NeuroAccess™ focused ultrasound system to treat Alzheimer's disease. The company is based in Mountain View, CA. Alzheimer's disease is a progressive disease that affects memory and makes up an estimated 60-80% of dementia cases. Cordance's solution is a non-invasive 30-minute outpatient clinic procedure that opens the blood-brain barrier precisely to physician-directed regions of the brain. The company's cornerstone patent has been granted claims in the US, AU, and ten other countries. The company was founded by Bhaskar Ramamurthy. The CEO is Ryan Dittamore. | - |
R. Huennekens | M | 59 |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 1 jaar |
David R. Paolino | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 11 jaar |
Ryan Dittamore | M | 49 |
Cordance Medical, Inc.
Cordance Medical, Inc. Medical SpecialtiesHealth Technology Cordance Medical, Inc. is a company that is developing the NeuroAccess™ focused ultrasound system to treat Alzheimer's disease. The company is based in Mountain View, CA. Alzheimer's disease is a progressive disease that affects memory and makes up an estimated 60-80% of dementia cases. Cordance's solution is a non-invasive 30-minute outpatient clinic procedure that opens the blood-brain barrier precisely to physician-directed regions of the brain. The company's cornerstone patent has been granted claims in the US, AU, and ten other countries. The company was founded by Bhaskar Ramamurthy. The CEO is Ryan Dittamore. | - |
Marco Gario | M | - | 13 jaar | |
Arthur Copstein | M | - |
Syntegra, Inc. /California/
Syntegra, Inc. /California/ Packaged SoftwareTechnology Services Syntegra, Inc. applies machine learning to create validated replicas of medical data. The company was founded by Michael Lesh and Ofer Mendelevitch and is headquartered in Mill Valley, CA. | 4 jaar |
Sean Kelleher | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | - |
Blake Richards | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | - |
Alexander Jonsson | M | - |
Cordance Medical, Inc.
Cordance Medical, Inc. Medical SpecialtiesHealth Technology Cordance Medical, Inc. is a company that is developing the NeuroAccess™ focused ultrasound system to treat Alzheimer's disease. The company is based in Mountain View, CA. Alzheimer's disease is a progressive disease that affects memory and makes up an estimated 60-80% of dementia cases. Cordance's solution is a non-invasive 30-minute outpatient clinic procedure that opens the blood-brain barrier precisely to physician-directed regions of the brain. The company's cornerstone patent has been granted claims in the US, AU, and ten other countries. The company was founded by Bhaskar Ramamurthy. The CEO is Ryan Dittamore. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Gonzague Issenmann | M | 51 | 10 jaar | |
Jacques Séguin | M | - | 7 jaar | |
Dianne Blanco | F | 77 | 2 jaar | |
Thierry Sommelet | M | 54 | - | |
Christophe Lottin | M | - | 3 jaar | |
Brian A. Kerr | M | - | - | |
Alexia Perouse | F | - | - | |
Paul Geudens | M | - | - | |
Anne-Sophie Herelle | F | 43 | - | |
Pierre Brégeard | M | - | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Frankrijk | 14 | 58.33% |
Verenigde Staten | 10 | 41.67% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Michael D. Lesh
- Persoonlijk netwerk